
Kathleen Kahler Fonda
Examiner (ID: 19471)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1211, 1623, 1621, 1803, 1622 |
| Total Applications | 685 |
| Issued Applications | 444 |
| Pending Applications | 93 |
| Abandoned Applications | 148 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20158149
[patent_doc_number] => 12384760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Substituted carbazole compounds
[patent_app_type] => utility
[patent_app_number] => 17/766392
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18138
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766392 | Substituted carbazole compounds | Oct 1, 2020 | Issued |
Array
(
[id] => 18160434
[patent_doc_number] => 20230027026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/764092
[patent_app_country] => US
[patent_app_date] => 2020-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -110
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764092 | FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF | Sep 25, 2020 | Pending |
Array
(
[id] => 18018919
[patent_doc_number] => 20220370418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/640978
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640978 | PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES | Sep 7, 2020 | Abandoned |
Array
(
[id] => 17930222
[patent_doc_number] => 20220325347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => GENETIC VARIANTS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/639065
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639065
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639065 | Genetic variants for diagnosis of Alzheimer's disease | Aug 24, 2020 | Issued |
Array
(
[id] => 17882697
[patent_doc_number] => 20220298174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/632167
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632167 | TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Aug 2, 2020 | Pending |
Array
(
[id] => 17865335
[patent_doc_number] => 20220288070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => DEUTERATED MK2 PATHWAY INHIBITORS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/630414
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630414 | Deuterated MK2 pathway inhibitors and methods of using the same | Jul 30, 2020 | Issued |
Array
(
[id] => 17836296
[patent_doc_number] => 20220273601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COLLAGEN PRODUCTION PROMOTER, WRINKLE IMPROVER, TOPICAL SKIN CARE COMPOSITION, AND BEAUTY FOOD OR BEVERAGE
[patent_app_type] => utility
[patent_app_number] => 17/631125
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631125 | COLLAGEN PRODUCTION PROMOTER, WRINKLE IMPROVER, TOPICAL SKIN CARE COMPOSITION, AND BEAUTY FOOD OR BEVERAGE | Jul 29, 2020 | Pending |
Array
(
[id] => 17830009
[patent_doc_number] => 20220267313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/597897
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597897 | DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES | Jul 29, 2020 | Pending |
Array
(
[id] => 17928319
[patent_doc_number] => 20220323444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => Methods of Treating Advanced Prostate Cancer
[patent_app_type] => utility
[patent_app_number] => 17/631366
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631366 | Methods of Treating Advanced Prostate Cancer | Jul 28, 2020 | Pending |
Array
(
[id] => 17866944
[patent_doc_number] => 20220289679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/630442
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630442 | HETEROCYCLIC COMPOUND | Jul 27, 2020 | Pending |
Array
(
[id] => 17791982
[patent_doc_number] => 20220251073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => CRYSTALLINE FORMS OF 7-CHLORO-2-(4-(3-METHOXYAZETIDIN-1-YL)CYCLOHEXYL)-2,4-DIMETHYL-N-((6-METHYL-4-(METHYLTHIO)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)BENZO[D][1,3]DIOXOLE-5-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/628947
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628947 | Crystalline forms of 7-chloro-2-(4-3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide | Jul 22, 2020 | Issued |
Array
(
[id] => 17866993
[patent_doc_number] => 20220289728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => MODULATORS OF TREX1
[patent_app_type] => utility
[patent_app_number] => 17/628946
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 423
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628946 | MODULATORS OF TREX1 | Jul 21, 2020 | Pending |
Array
(
[id] => 18075847
[patent_doc_number] => 20220401459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN PREVENTING RECURRENCE OF PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 17/775618
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775618 | NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN PREVENTING RECURRENCE OF PSORIASIS | Jun 11, 2020 | Pending |
Array
(
[id] => 20787434
[patent_doc_number] => 12661329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-23
[patent_title] => Methods of generating oligodendrocytes
[patent_app_type] => utility
[patent_app_number] => 17/618541
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 4762
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618541
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618541 | METHODS OF GENERATING OLIGODENDROCYTES | Jun 10, 2020 | Issued |
Array
(
[id] => 18057942
[patent_doc_number] => 20220389028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => BAX INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/615377
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615377 | Bax inhibitors and uses thereof | May 31, 2020 | Issued |
Array
(
[id] => 17913376
[patent_doc_number] => 20220315771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => REVERSIBLE CULTURAL RELIC PROTECTION MATERIAL WITH FUNCTION OF INHIBITING GROWTH OF BACTERIA AND MOLD
[patent_app_type] => utility
[patent_app_number] => 17/596224
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596224 | REVERSIBLE CULTURAL RELIC PROTECTION MATERIAL WITH FUNCTION OF INHIBITING GROWTH OF BACTERIA AND MOLD | May 31, 2020 | Abandoned |
Array
(
[id] => 17733187
[patent_doc_number] => 20220218646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => DIETARY BUTYRATE AND ITS USES
[patent_app_type] => utility
[patent_app_number] => 17/595516
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595516 | DIETARY BUTYRATE AND ITS USES | May 19, 2020 | Issued |
Array
(
[id] => 17702737
[patent_doc_number] => 20220202743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE USING AUTOPHAGY ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 17/610879
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610879
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610879 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE USING AUTOPHAGY ACTIVATION | May 12, 2020 | Abandoned |
Array
(
[id] => 17748135
[patent_doc_number] => 20220226338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Methods of Treating Cancer Using CHK1 Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/610198
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -170
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610198 | Methods of Treating Cancer Using CHK1 Inhibitors | May 12, 2020 | Pending |
Array
(
[id] => 17944296
[patent_doc_number] => 20220331313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/608820
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/608820 | METHODS FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION | May 5, 2020 | Pending |